Leo Pharma is actively seeking more acquisition targets, with as much as 5 billion kroner ($800 million) to spend on dealmaking as it positions itself for an initial public offering, according to its top management.
Leo Pharma Eyes $800 Million Deal Push as IPO Plans Advance
Leo Pharma is actively seeking more acquisition targets, with as much as 5 billion kroner ($800 million) to spend on dealmaking as it positions itself for an initial public offering, according to its top management.
This article was originally published by
Bloomberg Markets
and is republished here under license.
Leave a Reply